Northern Trust
VECT

Northern Trust’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Northern Trust’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,361
Closed -$17K – 4832
2021
Q4 		$17K Buy
+3,361
New +$16.6K ﹤0.01% 4721
2021
Q3 		– Sell
-7,159
Closed -$83K – 4772
2021
Q2 		$83K Buy
+7,159
New +$109K ﹤0.01% 4406

Other funds holding VECT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust's VECT Position: Q1 2022 in Review

Northern Trust sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q1 2022, closing a stake of 3,361 shares — an estimated $17K sold.

Northern Trust first reported a position in VECT in Q2 2021 and held it in 2 quarters. The position peaked at $83K in Q2 2021. 17 funds tracked by Wall St. Rank hold VECT as of Q1 2022.

  • Northern Trust reported no remaining VectivBio Holding AG Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Northern Trust sold 3,361 VectivBio Holding AG Ordinary Shares shares in Q1 2022, an estimated $17K.
  • Northern Trust first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 2 quarters.
  • Northern Trust's VectivBio Holding AG Ordinary Shares position peaked at $83K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q1 2022.

Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.